Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy
Authors:
- 1 April 2007
- journal article
- Published by Elsevier in Metabolism
- Vol. 56 (4) , 508-516
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Acquired and Inherited LipodystrophiesNew England Journal of Medicine, 2004
- Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat MassJournal of Biological Chemistry, 2003
- Serum Adiponectin and Leptin Levels in Patients with LipodystrophiesThe Journal of Clinical Endocrinology & Metabolism, 2002
- Leptin-Replacement Therapy for LipodystrophyNew England Journal of Medicine, 2002
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002
- Lipoatrophy RevisitedTrends in Endocrinology & Metabolism, 2000
- Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin DeficiencyNew England Journal of Medicine, 1999
- Recombinant Mouse OB Protein: Evidence for a Peripheral Signal Linking Adiposity and Central Neural NetworksScience, 1995
- Weight-Reducing Effects of the Plasma Protein Encoded by the obese GeneScience, 1995
- Effects of the obese Gene Product on Body Weight Regulation in ob / ob MiceScience, 1995